HIV Data Update
Presented by: Ruth Serrano, MD
Session 1 Objectives:
- Prevention
- Treatment
- Oral treatment options
- Long-acting injectables update
- Pregnancy
HIV Prevention and Care among Substance Using Populations
Presented by: Angela Heads, Ph.D.
Session 2 Objectives:
- Overview of HIV in the US – recent trends
- Describe the connections among substance use, and HIV prevention and care
- Barriers and facilitators to HIV prevention
- Recent and ongoing research in our center
Legislative Impact on HIV Care
Presented by: Aliza Norwood, MD
Session 3 Objectives:
- Recognize how anti-LGBTQ laws impact PLWHIV
- Discuss HIV criminalization in the U.S.
- Identify recent anti-LGBTQ laws
- Highlight ways to promote policies that improve health and wellness
Harm Reduction Methodologies
Presented by: Crystal Walker, DMSc, MPAS, PA-C
Session 4 Objectives:
- Describe harm reduction in the settings of substance use and HIV
- List at least three approaches to reducing risk and harm in individuals who inject drugs
- Apply strategies and principles of risk and harm reduction in the setting of Texas
Please email aetcinfo@uthscsa.edu for a copy of the slides
Mental Health and HIV
Presented by: Alex Young, PsyD.
Session 5 Objectives:
- Learn about the unique behavioral health challenges that patients with HIV face
- Discuss what we can do as a patient’s treatment team to empower and support them
- Discuss the future of HIV care from a behavioral health perspective using integration
COVID-19 and HIV
Presented by: Camille Spears, MD
Session 6 Objectives:
- Review status neutral HIV care continuum
- Review impacts of COVID-19 pandemic at each stage of the HIV care continua
- Explore next steps and paths forward